Request Demo
Last update 04 Feb 2025
Suzhou Pulekang Pharmaceutical Technology Co., Ltd.
Last update 04 Feb 2025
Overview
Basic Info
Introduction Pro-heal Pharmaceuticals was established in 2019 and is located in Suzhou, Jiangsu, China. Pro-heal Pharmaceuticals focuses on the development of innovative ophthalmic drugs, especially the development of new drugs for immune-related eye diseases, and the development of new drugs closely related to clinical needs and the cognition of ophthalmic immune mechanism. A number of candidate drugs with innovative mechanisms for the treatment of eye diseases will enter the clinical trial stage one after another, providing more unmet treatment means for patients with eye diseases. |
Tags
Immune System Diseases
Eye Diseases
Nervous System Diseases
Small molecule drug
Antibody
Fusion protein
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20222159
一项评价PHP1003在中国健康成年受试者中安全性、耐受性、药代动力学特征、免疫原性特征的随机、双盲、安慰剂对照、单次及多次剂量递增Ⅰ期临床研究
[Translation] A randomized, double-blind, placebo-controlled, single- and multiple-dose escalation Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics, and immunogenicity of PHP1003 in healthy adult subjects in China
CTR20244055
一项评价PHP1003在治疗中国中重度甲状腺眼病（TED）患者中的有效性和安全性的多中心、随机、双盲、安慰剂对照的Ⅱ期临床研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled Phase II clinical study to evaluate the efficacy and safety of PHP1003 in the treatment of moderate to severe thyroid eye disease (TED) in Chinese patients
CTR20243960
一项评价PHP0101滴眼液在中国老视患者中安全性、耐受性、药代动力学特征和初步有效性的随机、双盲、安慰剂对照的I期临床研究
[Translation] A randomized, double-blind, placebo-controlled Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of PHP0101 eye drops in Chinese presbyopic patients
100 Clinical Results associated with Suzhou Pulekang Pharmaceutical Technology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Suzhou Pulekang Pharmaceutical Technology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Suzhou Pulekang Pharmaceutical Technology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 07 May 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
2
Preclinical
Phase 1
1
1
Phase 2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free